ACTU insider trading
See Actuate Therapeutics (ACTU) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| SCHMITT DANIEL M | President, CEO and Director, Director | Buy | Oct 28, 2026 | Oct 29, 2026 | 140,844 | $0.35 | $50.00K | Filing |
| SCHMITT DANIEL M | President, CEO and Director, Director | Buy | Oct 28, 2026 | Oct 29, 2026 | 70,422 | $0.00 | $0.00 | Filing |
| THOMSON TODD S | Director, 10% owner | Sell | Jan 5, 2026 | Jan 7, 2026 | 280,000 | $5.80 | $1.62M | Filing |
| Bios Equity COF, LP | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $7.00 | $500.00K | Filing |
| Bios Equity COF, LP | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $0.00 | $0.00 | Filing |
| Kreis Leslie W. | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $7.00 | $500.00K | Filing |
| Kreis Leslie W. | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $0.00 | $0.00 | Filing |
| Fletcher Aaron G.L. | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $7.00 | $500.00K | Filing |
| Fletcher Aaron G.L. | Director, 10% owner | Buy | Jun 27, 2025 | Jun 30, 2025 | 71,428 | $0.00 | $0.00 | Filing |